Status:
UNKNOWN
Micrometastasis in Gastrointestinal Cancer
Lead Sponsor:
Oslo University Hospital
Conditions:
Pancreatic Adenocarcinoma
Colorectal Cancer
Eligibility:
All Genders
Brief Summary
Prognostic and predictive value of assessing the patients micrometastasis status in blood and bone marrow when diagnosed GI cancer. 2 different patient subgroups are currently studied, patients with c...
Detailed Description
Oncological and overall outcome of the included patients are consecutively registrated at the out-patient clinic. At end of follow-up these survival data are analysed according to the presence of tumo...
Eligibility Criteria
Inclusion
- Histological proven adenocarcinoma of the pancreas
- Histological/radiological verified colorectal liver metastases
- Consent capable patient
- Signed written, informed consent
Exclusion
- 1\. Patient'history of other malignancy
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01919151
Start Date
June 1 2008
End Date
December 1 2015
Last Update
August 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Oslo County, Norway, 0424